Abstract
Introduction: Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is a rare diagnosis, encompassing a group of related neuropathies that share the characteristics of chronicity, demyelination, inflammation, and immune-mediation. It exists along a temporal continuum with its acute counterpart: the demyelinating form of Guillain-Barre Syndrome (GBS), a monophasic illness which typically resolves in the span of weeks. First line treatments of CIDP include corticosteroids, intravenous immunoglobulin (IVIG), and plasma exchange, although more aggressive presentations may require additional immunotherapy. We present a case of CIDP in an adolescent patient. As a disease …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
